Detail Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?   Oleh:  Pavcnik, Nina Jenis: Article from Bulletin/Magazine Dalam koleksi: The Rand Journal of Economics vol. 33 no. 3 (2002), page 469-487. Topik: patent; pharmaceutical prices; potential patient; out - of - pocket Ketersediaan Perpustakaan Pusat (Semanggi) Nomor Panggil: RR10.7 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Isi artikel Despite the importance of patient insurance in the market for prescription pharmaceuticals, little is known about the impact of patient reimbursement on the pricing behavior of pharmaceutical firms. I examine the link between potential patient out - of - pocket expenses and pharmaceutical pricing using a unique policy experiment from Germany. Starting in 1989, a maximum reimbursement for a given medicine replaced a flat prescription fee. This change in reimbursement exposes the patient to the price of a prescribed product. Using a product - level panel dataset covering several therapeutic categories before and after the policy change, I find that producers significantly decrease prices after the change in potential patient out - of - pocket expenses. Price declines are most pronounced for brand - name products. Moreover, branded products that face more generic competitors reduce prices more. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved